RECAP 4/23 Chatter:
$CODX + $26M contracts in UT &amp; NE
$COCP + Patent
$GILD - Remdesivir Flops in First trial
$SDC - Refiling CA Claims
$CLBS - Offering
$BAX + Emergency Use Oxiris
$APT + $720K HHS order
$TIVO + $CMCSA ITC Royalty ruling
$ABT - COVID Test safety issues